CVS Health is a diversified healthcare company with interests in pharmacy, insurance, and primary care, but this diversification may hinder optimal growth compared to more focused companies like Novo Nordisk, which specializes in diabetes and weight management drugs.
For an investor focused on strategic asset allocation and portfolio diversification, consider the potential advantages of investing in Novo Nordisk (NYSE: NVO) due to its concentrated focus on metabolic diseases and leadership in the rapidly growing anti-obesity market. This specialization could offer more robust growth opportunities compared to a diversified company like CVS Health, where resources may be stretched across various segments.